A successful case of extracorporeal membrane oxygenation for COVID-19: walking home without oxygen supplementation

Tran, Douglas; Peng, Chung Kang; Wolde-Rufael, Daniel A.; Devkota, Hari Prasad; Diaz‐Abad, Montserrat; Baghdadi, Jonathan; Chow, Robert Dobbin; Verceles, Avelino C.

doi:10.1080/20009666.2021.1918442

Cited by 2 publications

(4 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We ultimately included nine studies, 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 seven of which were case reports. 14 , 15 , 16 , 17 , 18 , 19 , 21 Only two studies had more than one patient; an observational design analyzing the clinical course of 19 patients, 20 and a case series of three patients. 13 …”

Section: Methodsmentioning

confidence: 99%

“…We also excluded those articles not written in English. We ultimately included nine studies, [13][14][15][16][17][18][19][20][21] seven of which were case reports. [14][15][16][17][18][19]21 Only two studies had more than one patient; an observational design analyzing the clinical course of 19 patients, 20 and a case series of three patients.…”

Section: Methodsmentioning

confidence: 99%

“…Furthermore, in Tran et al's study, a patient who underwent veno-venous ECMO was able to ambulate autonomously after 35 days of support, although it was not clear if physiotherapy was initiated before or after decannulation. 21 Eventually, in another case study by Rajdev and colleagues, although it has been reported the patient underwent aggressive rehabilitation during hospitalization, it was not clear if the authors implemented the rehabilitative treatment with the patient on ECMO support. 19 Further consideration should be made on the patient's consciousness; it has already been clarified that awake ECMO can facilitate rehabilitative activities enhancing patients' outcomes.…”

Section: Rehabilitation While On Ecmo Supportmentioning

confidence: 99%

See 2 more Smart Citations

Extracorporeal membrane oxygenation and rehabilitation in patients with COVID‐19: A scoping review

Polastri¹,

Swol²,

Loforte³

et al. 2021

Artificial Organs

View full text Add to dashboard Cite

Background and purpose The coronavirus diseases 2019 (COVID‐19) pandemic posed severe difficulties in managing critically ill patients in hospital care settings. Extracorporeal membrane oxygenation (ECMO) support has been proven to be lifesaving support during the SARS‐CoV‐2 outbreak. The purpose of this review was to describe the rehabilitative treatments provided to patients undergoing ECMO support during the COVID‐19 pandemic. Methods We searched PubMed and Scopus for English‐language studies published from the databases’ inception until June 30, 2021. We excluded editorials, letters to the editor, and studies that did not describe rehabilitative procedures during ECMO support. We also excluded those articles not written in English. Results A total of 50 articles were identified. We ultimately included nine studies, seven of which were case reports. Only two studies had more than one patient; an observational design analyzing the clinical course of 19 patients and a case series of three patients. Extracorporeal support duration varied from 9 to 49 days, and the primary indication was acute respiratory distress syndrome COVID‐19‐related. Rehabilitative treatment mainly consisted of in‐bed mobilization, postural transfers (including sitting), and respiratory exercises. After hospital discharge, patients were referred to rehabilitation facilities. Physiotherapeutic interventions provided during ECMO support and after its discontinuation were feasible and safe. Conclusion The physiotherapeutic treatment of patients undergoing ECMO support includes several components and must be provided in a multidisciplinary context. The optimal approach depends on the patient’s status, including sedation, level of consciousness, ECMO configuration, types of cannulas, and cannulation site.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Rehabilitation While On Ecmo Supportmentioning

confidence: 99%

See 1 more Smart Citation

Extracorporeal membrane oxygenation and rehabilitation in patients with COVID‐19: A scoping review

Polastri¹,

Swol²,

Loforte³

et al. 2021

Artificial Organs

View full text Add to dashboard Cite

show abstract

“…Extracorporeal membrane oxygenation (ECMO) experienced remarkable progress over recent years, and represents a crucial therapeutic approach for late-stage ARDS [ 45 ]. Lung injury and function can recover on ECMO within weeks to months [ 46 ].…”

Section: Lung Transplantation For Sars-cov-2 Infection—associated Ard...mentioning

confidence: 99%

How COVID-19 Affects Lung Transplantation: A Comprehensive Review

Vachtenheim

Novysedlák

Svorcova

et al. 2022

JCM

View full text Add to dashboard Cite

Lung transplant (LuTx) recipients are at a higher risk of developing serious illnesses from COVID-19, and thus, we have closely reviewed the consequences of the COVID-19 pandemic on lung transplantation. In most transplant centers, the overall LuTx activity significantly declined and led to a specific period of restricting lung transplantation to urgent cases. Moreover, several transplant centers reported difficulties due to the shortage of ICU capacities. The fear of donor-derived transmission generated extensive screening programs. Nevertheless, reasonable concerns about the unnecessary losses of viable organs were also raised. The overall donor shortage resulted in increased waiting-list mortality, and COVID-19-associated ARDS became an indication of lung transplantation. The impact of specific immunosuppressive agents on the severity of COVID-19 varied. Corticosteroid discontinuation was not found to be beneficial for LuTx patients. Tacrolimus concentrations were reported to increase during the SARS-CoV-2 infection, and in combination with remdesivir, tacrolimus may clinically impact renal functions. Monoclonal antibodies were shown to reduce the risk of hospitalization in SOT recipients. However, understanding the pharmacological interactions between the anti-COVID-19 drugs and the immunosuppressive drugs requires further research.

show abstract

A successful case of extracorporeal membrane oxygenation for COVID-19: walking home without oxygen supplementation

Cited by 2 publications

References 14 publications

Extracorporeal membrane oxygenation and rehabilitation in patients with COVID‐19: A scoping review

Extracorporeal membrane oxygenation and rehabilitation in patients with COVID‐19: A scoping review

How COVID-19 Affects Lung Transplantation: A Comprehensive Review

Contact Info

Product

Resources

About